Neurological Associates of Tucson DBA Center for Neurosciences — research payments reported

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$221,074	30
2024	Research	$223,995	11
2023	Research	$33,642	3

Breakdown

Who paid Research payments · program years 2023–2025

Cochlear Americas $445,069 41 payments
Takeda Pharmaceuticals U.S.A., Inc. $33,642 3 payments

Studies the money was for Research payments · program years 2023–2025

A pivotal, prospective, open-label, multi-arm, multi-center non-randomized study of safety and effectiveness of cochlear implantation in an expanded population of adults with bilateral sensorineural hearing loss $438,842 36 payments
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS) $33,642 3 payments
A pivotal, prospective, open-label, multi-arm, multi-center non-randomized study of safety and effectiveness of cochlear implantation in an expanded population of adults with bilateral sensorineural hearing loss $5,727 4 payments
A pivotal, prospective, open-label, multi-arm, multi-center non-randomized study of safety and effectiveness of cochlear implantation in an expanded population of adults with bilateral sensorineural hearing loss $500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.